U.S.
FDA Approves First-of-Its
Facts
- FDA approved antisense oligonucleotide to treat chronic hepatitis B. [1]
Sources (1)
Primary source
Food and Drug AdministrationOriginal title FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment
Published Oct 20, 2026